Targeting AKR1B1 inhibits metabolic reprogramming to reverse systemic therapy resistance in hepatocellular carcinoma.
靶向 AKR1B1 可抑制代谢重编程，从而逆转肝细胞癌的全身治疗耐药性
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02321-9
Wang Qi, Liu Juan, Yang Ming, Zhou Jun, Li Yaxuan, Zheng Jingjing, Jia Hao, Yue Shuhua, Le Yinpeng, Su Yuxin, Ma Wenrui, An Ni, Wang Yunfang, Dong Jiahong
